Eco Animal Health Sustainability Profile
Eco Animal Health Ltd, headquartered in Great Britain, is a leading player in the global animal health industry, specialising in innovative solutions for livestock and aquaculture. Founded in 2004, the company has made significant strides in developing unique products that enhance animal welfare and productivity. With a strong presence in Europe, Asia, and the Americas, Eco Animal Health focuses on a range of core services, including the development of pharmaceuticals and nutritional products tailored for various species. Their flagship products, such as Aivlosin® and EcoVax®, are renowned for their efficacy and safety, setting them apart in a competitive market. Recognised for their commitment to research and development, Eco Animal Health has achieved notable milestones, positioning themselves as a trusted partner in animal health management worldwide.
DitchCarbon Score
How does Eco Animal Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eco Animal Health's score of 64 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eco Animal Health's reported carbon emissions
In 2024, Eco Animal Health reported total carbon emissions of approximately 50390000 kg CO2e for Scope 1, 33157000 kg CO2e for Scope 2 (market-based), and about 569110000 kg CO2e for Scope 3 emissions. This data reflects a commitment to transparency and accountability in their climate impact. The company has set an ambitious target to reduce its greenhouse gas emissions by 42% across all scopes by the end of 2030, using 2021 as the baseline year. This target aligns with the Science Based Targets initiative (SBTi) and demonstrates Eco Animal Health's dedication to mitigating climate change. In previous years, emissions were reported as follows: in 2023, Scope 1 emissions were about 50946000 kg CO2e, Scope 2 emissions (market-based) were approximately 33509000 kg CO2e, and Scope 3 emissions totalled around 579580000 kg CO2e. In 2022, the figures were 53287000 kg CO2e for Scope 1, 32165000 kg CO2e for Scope 2 (market-based), and 604126000 kg CO2e for Scope 3. The emissions data is cascaded from the parent company, ECO Animal Health Group plc, indicating a structured approach to sustainability within the corporate family. Eco Animal Health's commitment to reducing its carbon footprint is a significant step towards achieving broader climate goals in the animal health industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 9,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 11,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Eco Animal Health's Industry?
How Carbon Intensive is Eco Animal Health's Location?
Eco Animal Health's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eco Animal Health has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
